Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update showing the safety and efficacy evaluation of Jaktinib in adults with alopecia areata; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Jaktinib (jaktinib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Alopecia Areata | Phase 3 | Status: COMPLETED